Sudair Pharma proudly participated in the Global Health Exhibition 2025, showcasing its latest achievements in pharmaceutical innovation, advanced manufacturing, and national talent development.
One of the most significant moments of the event was the honor of welcoming His Excellency the Minister of Health, Fahad Al-Jalajel, whose visit underscored the national priority of strengthening local drug manufacturing and ensuring medical security across Saudi Arabia.
During the tour, His Excellency was briefed on Sudair Pharma’s role in localizing advanced pharmaceutical technologies, its key initiatives in producing vital medications, and its contribution to building a competitive and sustainable healthcare ecosystem aligned with Saudi Vision 2030.
Sudair Pharma also had the pleasure of receiving several distinguished guests, including:
– Dr. Khalid Al-Buraikan, Deputy Minister for Health Investment
– Dr. Mohammed Al-Abd Al-Ali, Assistant Minister for Healthcare Services
– Senior representatives from government and private healthcare entities
Their visits highlighted the importance of public-private collaboration in accelerating growth in the Saudi pharmaceutical sector.
Sudair Pharma’s presence at GHE 2025 reflected its commitment to innovation, quality, and national capability-building. Through continuous investment and strategic partnerships, the company remains dedicated to supporting the Kingdom’s journey toward a healthier and more self-reliant future.
